
British pharmaceutical giant AstraZeneca, who has joined hands with the University of Oxford was one of the first ones to produce a vaccine prototype which reached the clinical trial stage. After early hiccups and observations, the researchers have now said that they are all set to "roll out" their vaccine candidate for the masses in the months of September or October, with production for two million doses underway.
ETimes
No comments:
Post a Comment